We are studying two enzymes from the shikimate pathway, dehydroquinate synthase (DHQS) and 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). Both enzymes have been the subject of numerous studies to elucidate their reaction mechanisms. Crystal structures of DHQS and EPSPS in the presence and absence of substrates, cofactors and/or inhibitors are now available. These structures reveal movements of domains, rearrangements of loops and changes in side-chain positions necessary for the formation of a catalytically competent active site. The potential for using complementary small-angle X-ray scattering (SAXS) studies to confirm the presence of these structural differences in solution has also been explored. Comparative analysis of crystal structures, in the presence and absence of ligands, has revealed structural features critical for substrate-binding and catalysis. We have also analysed these structures by generating GRID energy maps to detect favourable binding sites. The combination of X-ray crystallography, SAXS and computational techniques provides an enhanced analysis of structural features important for the function of these complex enzymes.
Background
The shikimate pathway
The shikimate pathway links the metabolism of carbohydrates to the biosynthesis of ring-containing compounds. The pathway is composed of seven steps which take the exogenous substrates, phosphoenol pyruvate and 4-erythrose phosphate, to yield chorismate [1, 2] . The latter compound is the precursor to the synthesis of aromatic compounds including folate, p-aminobenzoate and the aromatic amino acids. The shikimate pathway is present in bacteria, microbial eukaryotes, certain parasites and plants. Mammals lack the shikimate pathway and have to obtain many aromatic compounds from their diet. This pathway is the target of the inhibitor glyphosate (N-phosphomethyl glycine [3] ), the active ingredient in the well-known herbicide Roundup R (Monsanto). However, glyphosate was also shown to inhibit the growth of several apicomplexan parasites, including those that cause malaria and toxoplasmosis [4] . As a result, the pathway is also considered a potential target for the development of new anti-microbial and anti-parasitic compounds [5] .
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Enzyme mechanism
Dehydroquinate synthase (DHQS) and 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) catalyse the second step and the sixth (penultimate) step, respectively, of the shikimate pathway. DHQS is an NAD-dependent metalloenzyme that converts 3-deoxy-D-arabino-heptulosonate 7-phosphate ('DAHP') into 3-dehydroquinate (Scheme 1). DHQS utilizes a complex multi-step mechanism which includes alcohol oxidation, phosphate β-elimination, carbonyl reduction, ring opening and intramolecular aldol condensation [6] . Of the numerous compounds synthesized to study the function of DHQS, the slowly reversible inhibitor carbaphosphonate (Scheme 1) has been particularly useful for understanding the early steps of the catalysed reaction [7, 8] , as well as identifying critical interactions in the first high-resolution crystal structure of the enzyme [9] .
EPSPS catalyses the conversion of shikimate 3-phosphate (S3P) and phosphoenolpyruvate into enolpyruvylshikimate 3-phosphate ('EPSP') [9] (Scheme 2). EPSPS is the target of glyphosate [10] (Scheme 2). The first structure of an EPSPS was published in the form of the main-chain Cα atoms only, without the full co-ordinates or ligands, in 1991 [11] . The complex of EPSPS with S3P and glyphosate was subsequently solved by ourselves (E.P. Carpenter and K.A. Brown, unpublished work) and others [12] . 
Comparative analysis of ligand-induced structural changes

Crystallographic studies
We have obtained the crystal structure of Aspergillus nidulans DHQS in complex with NAD + and Zn 2+ only, to complement our structure of the complex with carbaphosphonate [9] . DHQS is a dimer with two domains in each monomer ( Figure 1a) . Each monomer has one active site, situated between the N-terminal and C-terminal domains of the monomer (known as domain 1 and domain 2, respectively). Residues that are important for catalysis and binding come from both domains of one monomer together with the side chain of Arg-130 from the other monomer [9] . In the structure without carbaphosphonate, the domains move apart, creating a cleft near the substrate-binding site, referred to here as the 'open' conformation. The NAD + and Zn 2+ remain bound in the cleft, interacting mainly with domain 1 or domain 2, respectively. A rotation of 14
• about the axis shown in Figure 1 is necessary to close the active site when substrate or inhibitor are bound. Residues Leu-183 and ProScheme 2 The EPSPS-catalysed reaction and structure of the inhibitor glyphosate PEP, phosphoenolpyruvate; EPSP, enolpyruvylshikimate 3-phosphate.
184 act as the hinge between the two domains. This brings domain 2 of DHQS into contact with domain 1 of the other monomer of the dimer. When the domains come together to form the 'closed' conformation in the presence of carbaphosphonate, there are substantial changes in two loops (shown in red in Figures 1a  and 1b) , which appear to be critical for formation of the catalytically competent active site. The loop between residues 256 and 262 moves substantially upon inhibitor binding, with previously disordered residues, Glu-258 and Arg-259, becoming ordered. Similarly, the entire loop region between residues 355 and 363 is disordered in the open conformation and ordered in the closed conformation. Movement and ordering of these loops bring into the active site the side chain of Lys-356, which binds to the phosphonate moiety of the inhibitor. These loops also have a number of residues which interact with catalytically important residues: the main-chain carbonyl group of Glu-258 interacts with Arg-264, which stabilizes the carboxylate moiety of the inhibitor; the side chain of Glu-260 forms a salt bridge with Lys-152, which binds both the phosphonate and carboxylate moieties of the inhibitor; the side chains of both Asp-355 and Lys-357 hydrogen bond to Asn-268 (the former via a salt bridge to Lys-357 and also a hydrogen bond to a water molecule), thus positioning Asn-268 where it can bind to both the phosphonate and the C-2 hydroxyl groups of the inhibitor.
These two flexible loops also form contact regions between the two domains of the monomer when the active site closes. These loops form hydrogen bonds between the side chains of Glu-258 (domain 2) and Gln-169 (domain 1) and also between Lys-356 (domain 2) and the backbone carbonyl of Asn-162 (domain 1). In addition, there are numerous watermediated contacts, such as the link between the side chain of Arg-259 and the nitrogen and carbonyl of Ile-167 via two water molecules. These loops also appear to mediate interactions between the two monomers of the dimer when the active site is closed. In the closed conformation the loop between residues 354 and 360 of one monomer packs against a loop formed by residues 100-106 from the other monomer. Several water molecules lie between these loops, providing intersubunit hydrogen bonds. The intersubunit contact is further stabilized by a series of interactions between the two flexible loops on one monomer and Arg-105 on the other monomer. In particular, the side-chain guanidino group and main-chain carbonyl and nitrogen groups of Arg-105 form hydrogen bonds (in some cases with one intermediate water molecule) with the main-chain carbonyl groups of Arg-259
and Glu-260, the side chain of Asn-265, and the main-chain carbonyl groups of Lys-356 and Asn-358. Our crystal structures have therefore shown that the catalytically competent active site of DHQS is formed in the presence of inhibitor (and presumably substrate), which induces a closure of the active-site cleft from an open conformation. The monomers and their respective domains come together and the two critical loops between residues 256-262 and residues 353-364 move into the active site. The side chain of Lys-356 is positioned into the active site where it can interact with the substrate/inhibitor, as well as with other active-site residues. The two loops also provide critical contacts between the domains of the monomer and between monomers of the dimer. The end result is an active site that is shielded from solvent and thus provides an isolated environment to ensure that only the correct product is formed in the complex multi-step reaction of DHQS [9] .
In comparison, even larger conformational changes are observed in Escherichia coli EPSPS (Figures 1c and 1d) . We have solved the open conformation of EPSPS to 2.1 Å and this structure was compared with the glyphosate and S3P complex structures solved by ourselves and Schönbrunn and colleagues [12] . A domain movement involving a rotation of 64
• about the axis shown in Figure 1 (c) occurs to close the active site. When the complex is formed, two loops, residues 163-170 and residues [193] [194] [195] [196] [197] [198] , and the first turn of the helix containing residues 197-210, move towards the active site (these sections are shown in red in Figures 1c and  1d ). This movement reorients the carbonyl group of Val-168 and moves the previously disordered side chains of Ser-197 and Tyr-200 so that they can interact with S3P. Formation of the closed conformation also reorients Glu-341 and Lys-411 into the active site. In the open conformation of EPSPS these residues point away from the region of the active site and are disordered.
It is therefore clear that in both DHQS and EPSPS there are movements on the scale of domains, loops and individual side chains that are necessary for the active site to form. In order to confirm that these differences in structure are representative of the structures in solution, we have used small-angle X-ray scattering (SAXS) methods to study these proteins in solution.
Solution studies
SAXS [13] differs from X-ray crystallography in that solutions, rather than crystals, are used and rotationally averaged scattering patterns are obtained at small scattering angles. The method can yield structural information about macromolecules in solution using proteins from as small as 6 kDa [14] to large macromolecular complexes such as the ribosome [15] . SAXS is particularly powerful for studying multi-protein assembly and conformational changes of proteins in solution. The methods to compute solution scattering patterns accurately from atomic models and rapidly evaluate scattering from complex particles are now well established [16] [17] [18] . The availability of crystal structures for both ligand-bound and ligand-free forms of DHQS [9] and EPSPS [11, 12] can be used to study the oligomeric state of these enzymes as well as the conformational states of these proteins upon the addition of substrates/inhibitors. For example, in the case of Aspergillus nidulans DHQS, SAXS data indicate that this enzyme is indeed a dimer in solution, which is further evidence that the dimer observed in the crystal structure [9] is unlikely to be an artifact arising from the crystallization conditions. In the case of E. coli EPSPS, addition of compounds such as S3P and glyphosate results in an overall decrease in the radius of gyration, which is also consistent with the crystal structure of the ligand-bound form of the enzyme [12] .
GRID
The program GRID has been used to analyse the binding potential of the active sites of both these enzymes. GRID is a computational program for detecting energetically favourable binding sites on molecules of known threedimensional structure such as drugs and macromolecules (proteins, nucleic acids, glycoproteins or polysaccharides) [19] [20] [21] . These energies are calculated as Lennard-Jones, electrostatic and hydrogen-bond interactions between a small chemical group called a probe and a given target molecule, using a position-dependent dielectric function to modulate the strong electrostatic interaction between charged centres. GRID maps can also be used as chemical descriptors for input into statistical procedures like CoMFA, GOLPE or SIMCA for QSAR or 3D-QSAR analyses [22] . The best-known application of GRID in structure-based drug design [23] shows the potential of the approach, where potent inhibitors based on the crystal structure of influenza virus sialidase were designed, leading to the approved drug Relenza R from Glaxo.
Several probes have been used [such as hydrophobic (DRY), water (OH2), phenolic hydroxyl (OH) and a zinc cation (ZN+2)] to examine and compare the open and closed forms of DHQS and EPSPS in the presence and absence of substrate and zinc (in the case of DHQS). Subsequent analysis of GRID energy maps indicates that favourable binding sites are present for substrate-cation interactions, consistent with the observed crystal structures. The method also has the potential to reveal localized variations in the chemical environments which may be associated with conformational changes upon ligand binding.
Summary
Conformational mobility and structural rearrangement are an integral part of the functional properties of the DHQS and EPSPS enzymes presented here. Crystallographic studies have demonstrated that a time-averaged 'snap shot' of DHQS and EPSPS can be obtained in the presence or absence of ligands. Co-ordinate comparisons provide a means to identify regions of the structure which change in response to the presence of substrates and/or inhibitors. However, the availability of these co-ordinate sets also provide a means for comparison of the effects of ligand-induced conformational changes in solution using SAXS methods. Furthermore, the coordinates also provide the necessary prerequisite for a more detailed analysis of the chemical features responsible for binding and catalysis using energy-based calculations such as GRID. The combination of all these techniques therefore allows a more dynamic image of enzyme function to emerge, particularly where conformational changes (e.g. 'twists and turns') play a significant role.
